SCHEMBL7898569

SCHEMBL7898569

CCSC(=NCCc1ccccc1)Nc1ccc(Oc2ccc(NC(=NCCc3ccccc3)SCC)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 5/20 0.47
HPGD P15428 2/20 0.43
NPC1 O15118 1/20 0.43
CRHBP P24387 1/20 0.43
RAB9A P51151 1/20 0.43
CRHR2 Q13324 1/20 0.43
HDAC1 Q13547 1/20 0.43
GAA P10253 3/20 0.42
KMT2A Q03164 3/20 0.42
NOS3 P29474 2/20 0.42
NOS1 P29475 2/20 0.42
NOS2 P35228 2/20 0.42
MEN1 O00255 2/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 5/20 0.41
ALOX12 P18054 1/20 0.41
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RECQL P46063 1/20 0.40
HTT P42858 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7896868 0.88 NPY5R (0.50) NPY5RHPGDNPC1CRHBPRAB9A
SCHEMBL7019465 0.77 NPY5R (0.49) NPY5RHPGDNPC1CRHBPRAB9A
SCHEMBL9528131 0.76 MAPT (0.45) NPC1RAB9AGAAKMT2AMAPT
SCHEMBL10981563 0.71 ALDH1A1 (0.47) HDAC1GAAKMT2AMEN1ALDH1A1
SCHEMBL1387462 0.71 HPGD (0.54) NPY5RHPGDNPC1CRHBPRAB9A
Iodide SCHEMBL7787919 0.70 HPGD (0.52) NPY5RHPGDNPC1CRHBPRAB9A
SCHEMBL9531721 0.68 MAPT (0.44) NPC1RAB9AGAAKMT2AMEN1
SCHEMBL8471745 0.66 HPGD (0.49) HPGDNPC1CRHBPRAB9ACRHR2
SCHEMBL21675987 0.66 IDO1 (0.51) HPGDNPC1RAB9AGAAKMT2A
SCHEMBL11584030 0.65 NOS3 (0.54) HPGDHDAC1GAAKMT2ANOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5958983-A NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY AGAINST HERPES, TOPICAL ADMINISTRATION THEM TO TREAT PATIENTS WITH HERPES; WORK BY INHIBITING THE INITIATION OF HERPES VIRAL DNA SYNTHESIS IN HOST CELLS PHARMACIA & UPJOHN COMPANY (US) 1999-09-28 US claimed
EP-1148048-A2 Polyaromatic antiviral compositions PHARMACIA & UPJOHN COMPANY (US) 2001-10-24 EP disclosed
US-6147116-A TOPICALLY ADMINISTERING BENZENE DERIVATIVE SUBSTITUTED WITH UREIDO-, THIOUREIDO, AND/OR SULFONAMIDO GROUPS TO TREAT HERPES PHARMACIA & UPJOHN COMPANY (US) 2000-11-14 US disclosed
US-5958983-A NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY AGAINST HERPES, TOPICAL ADMINISTRATION THEM TO TREAT PATIENTS WITH HERPES; WORK BY INHIBITING THE INITIATION OF HERPES VIRAL DNA SYNTHESIS IN HOST CELLS PHARMACIA & UPJOHN COMPANY (US) 1999-09-28 US disclosed